demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID-19 (hospitalized or not)
tocilizumab Hong Zhao

2 studies excluded by filtering options 1

5366 Rimland, 2020 2300excludednot a RCTrisk of bias not avaialble
5621 Ip, 2020 0134selection pending